REG - GreenX Metals Ltd - Issue of Shares

GreenX MetalsAnnouncement

10/02/2026 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260210:nRSJ3973Sa&default-theme=true

RNS Number : 3973S  GreenX Metals Limited  10 February 2026

 

NEWS RELEASE | 10 February 2026

 

ISSUE OF SHARES

 

GreenX Metals Limited (GreenX or Company) advises that further to its
announcements made on 24 November 2025, 2 December 2025, 12 December 2025 and
28 January 2026 the Company has issued the following ordinary fully paid
shares (Shares):

·      2,799,099 Shares on the exercise of 4,775,000 unlisted options
pursuant to cash and cashless exercise facilities;

·      3,487,147 Shares as deferred consideration for the acquisition of
90% of the Tannenberg Copper Project;

·      1,141,409 and 220,000 Shares as deferred consideration for the
acquisition of the Eleonore North Project and to a consultant in lieu of cash,
respectfully; and

·      16,000,000 Shares on completion of the Placement to raise gross
proceeds of A$13.6 million.

An application has been made for the admission of 23,647,655 Shares to the
Equity shares (international commercial companies secondary listing) listing
segment of the Official List of the FCA (Official List) and to trading on the
main market of the London Stock Exchange for listed securities (LSE
Admission). LSE Admission is expected to take place on or about 20 February
2026.

For the purposes of the Financial Conduct Authority's Disclosure Guidance and
Transparency Rules (DTRs), following LSE Admission, the Company's issued
ordinary share capital will be 310,730,744 ordinary shares. The above figure
of 310,730,744 may be used by shareholders as the denominator for the
calculations by which they can determine if they are required to notify their
interest in, or a change to their interest in, the Company following LSE
Admission.

GreenX has the following securities on issue:

·      310,730,744 ordinary fully paid shares;

·      11,000,000 performance rights that have an expiry date 8 October
2026;

·      5,525,000 unlisted options exercisable at A$0.55 each on or
before 30 November 2026;

·      7,100,000 unlisted options exercisable at A$1.05 each on or
before 31 May 2029; and

·      7,100,000 unlisted options exercisable at A$1.20 each on or
before 31 May 2030.

As disclosed and predicted in the Company's announcement on 30 January 2026,
the Company confirms that Poland has now applied to the Court of Appeal of the
Republic of Singapore to appeal the dismissal of the ECT set-aside motion
(refer to announcement dated 9 January 2026).

The threshold to succeed on a set aside motion in the Singapore courts is very
high, with the courts rejecting set-aside applications in the vast majority of
cases.

Please refer to the Company's announcements on 9 January 2026 and 30 January
2026 for further details.

 

Enquiries:

 

 Ben Stoikovich            Kazimierz Chojna

 Chief Executive Officer   Investor Relations - Poland

 +44 207 478 3900          Kim Eckhof

 ir@greenxmetals.com       Investor Relations - UK / Germany

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  IOEAKKBQPBKKFBD



            Copyright 2019 Regulatory News Service, all rights reserved